BriaCell Therapeutics Corp. (NASDAQ:BCTX) stock plunged on Wednesday after rallying on Tuesday on positive data from a breast cancer trial. This small biotechnology company, focused on cancer, has a market capitalization of approximately $20.57 million, according to data from Benzinga Pro. Capital…
Continue reading...